Sutro Biopharma Inc.
(STRO)
undefined
undefined%
At close: undefined
2.12
0.47%
After-hours Dec 13, 2024, 07:42 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 69.27M | 47.25M | 30.41M | 206.15M | 4.96M | 125.30M | 22.02M | 11.59M |
Short-Term Investments | 306.35M | 287.11M | 167.52M | 161.99M | 112.90M | 79.19M | - | 35.93M |
Long-Term Investments | - | 32.02M | 68.78M | 872.00K | 15.61M | 15.00K | 223.00K | 482.00K |
Other Long-Term Assets | 4.44M | 14.39M | 2.53M | 2.12M | 2.56M | 2.24M | 920.00K | 417.00K |
Receivables | 36.08M | 7.12M | 12.45M | 5.56M | 6.30M | 2.49M | 1.62M | 577.00K |
Inventory | - | -11.67M | 1.00 | - | - | 1.00 | - | - |
Other Current Assets | 9.85M | 11.67M | 8.12M | 4.49M | 8.81M | 5.93M | 1.99M | 1.59M |
Total Current Assets | 421.54M | 309.47M | 218.51M | 378.18M | 128.57M | 209.95M | 25.63M | 49.69M |
Property-Plant & Equipment | 44.76M | 51.06M | 51.59M | 12.94M | 9.63M | 10.93M | 14.00M | 18.69M |
Goodwill & Intangibles | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 49.19M | 97.48M | 122.89M | 15.93M | 27.80M | 13.19M | 15.14M | 19.59M |
Total Assets | 470.74M | 406.94M | 341.41M | 394.11M | 156.37M | 223.14M | 40.77M | 69.28M |
Account Payables | 9.44M | 4.80M | 6.01M | 5.54M | 5.58M | 3.06M | 2.90M | 3.39M |
Deferred Revenue | 20.67M | 106.64M | 5.50M | 14.60M | 19.46M | 21.57M | 10.71M | 43.58M |
Short-Term Debt | 16.90M | 21.67M | 11.45M | - | 1.00M | 4.72M | 14.56M | - |
Other Current Liabilities | 31.57M | 23.32M | 18.78M | 9.45M | 6.92M | 7.06M | 3.78M | 3.21M |
Total Current Liabilities | 93.75M | 139.47M | 41.74M | 29.60M | 32.97M | 36.42M | 31.96M | 50.18M |
Long-Term Debt | 23.15M | 33.34M | 46.96M | 24.55M | 8.88M | 10.00M | - | - |
Other Long-Term Liabilities | 150.81M | 119.00K | 146.00K | 1.82M | 543.00K | 578.00K | 104.66M | 104.14M |
Total Long-Term Liabilities | 227.34M | 50.43M | 47.11M | 32.47M | 25.61M | 55.18M | 117.81M | 110.00M |
Total Liabilities | 321.09M | 189.90M | 88.84M | 62.06M | 58.58M | 91.60M | 149.77M | 160.18M |
Total Debt | 33.63M | 67.52M | 57.37M | 24.55M | 9.88M | 14.72M | 14.63M | 1.19M |
Common Stock | 61.00K | 58.00K | 46.00K | 46.00K | 23.00K | 23.00K | - | 16.00K |
Retained Earnings | -559.41M | -452.62M | -333.41M | -227.87M | -195.75M | -150.33M | -115.01M | -95.32M |
Comprehensive Income | 21.00K | -618.00K | -314.00K | 129.00K | 165.00K | -47.00K | -208.00K | -17.00K |
Shareholders Equity | 149.65M | 217.05M | 252.56M | 332.05M | 97.79M | 131.54M | -109.00M | -90.90M |
Total Investments | 306.35M | 287.11M | 236.30M | 161.99M | 128.51M | 79.19M | 223.00K | 35.93M |